KENGREAL (cangrelor)

**Product type:** Human Prescription Drug

**Active ingredient:** CANGRELOR

**Strength:** 50 mg/1

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** Chiesi USA, Inc.

**Marketing category:** NDA (NDA204958)

**Pharmacologic class:** Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]